Chris has more than 20 years of biopharma development experience, with an emphasis on program management, CMC, and process development. He has built and led teams both in the US and Europe that were involved in a variety of programs from early stage development through to commercial launch and supply. As VP of Operations at Axial Biotherapeutics, Chris is responsible for Program Management, Clinical Operations, and Facilities/IT. Currently, Chris is focused on executing Axial’s clinical trials in both Autism and Parkinson’s Disease. Prior to joining Axial, Chris held various roles at companies including Lonza, Momenta, OvaScience, and Alkermes. He holds a BSc in Mechanical Engineering from Worcester Polytechnic Institute (WPI) and an MBA in International Business from Northeastern University.